Hirsch MS, Watkins J (mai 2020). „A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls”. Advances in Anatomic Pathology. 27 (3): 164–192. doi:10.1097/PAP.0000000000000238. PMID31149908.
Biomarkers Definitions Working Group (martie 2001). „Biomarkers and surrogate endpoints: preferred definitions and conceptual framework”. Clinical Pharmacology and Therapeutics (Review). 69 (3): 89–95. doi:10.1067/mcp.2001.113989. PMID11240971. as cited in Siderowf A, Aarsland D, Mollenhauer B, Goldman JG, Ravina B (aprilie 2018). „Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials”. Movement Disorders (Review). 33 (4): 528–536. doi:10.1002/mds.27355. PMID29624752.
nih.gov
ncbi.nlm.nih.gov
Hirsch MS, Watkins J (mai 2020). „A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls”. Advances in Anatomic Pathology. 27 (3): 164–192. doi:10.1097/PAP.0000000000000238. PMID31149908.
Biomarkers Definitions Working Group (martie 2001). „Biomarkers and surrogate endpoints: preferred definitions and conceptual framework”. Clinical Pharmacology and Therapeutics (Review). 69 (3): 89–95. doi:10.1067/mcp.2001.113989. PMID11240971. as cited in Siderowf A, Aarsland D, Mollenhauer B, Goldman JG, Ravina B (aprilie 2018). „Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials”. Movement Disorders (Review). 33 (4): 528–536. doi:10.1002/mds.27355. PMID29624752.
